Renal function and dapagliflozin in routine clinical practice

J Diabetes. 2015 Jul;7(4):591-2. doi: 10.1111/1753-0407.12291. Epub 2015 May 6.

Authors

Thinzar Min^{1

2}, Joel Handley¹, David Williams¹, David E Price¹, Jeffrey W Stephens^{1

2}

Affiliations

¹ Department of Diabetes & Endocrinology, Morriston Hospital, ABM University, Health Board, UK.
² Diabetes Research Group, Institute of Life Sciences, Swansea University, Swansea, UK.

PMID: 25817445
DOI: 10.1111/1753-0407.12291

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Animals
Humans
Hypoglycemic Agents / pharmacology*
Kidney / drug effects*
Kidney / physiology*
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Angiotensin-Converting Enzyme Inhibitors
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors